Oncotarget

Research Papers:

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells

Chiara Di Stefano, Paola Grazioli, Rosaria Anna Fontanella, Paola De Cesaris, Antonella D'Amore, Michele Regno, Donatella Starace, Fabrizio Padula, Micol Elena Fiori, Rita Canipari, Antonella Stoppacciaro, Margherita Pesce, Antonio Filippini, Antonio Francesco Campese _, Elio Ziparom and Anna Riccioli

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:30905-30918. https://doi.org/10.18632/oncotarget.25773

Metrics: PDF 605 views  |   HTML 1296 views  |   ?  


Abstract

Chiara Di Stefano1, Paola Grazioli2, Rosaria Anna Fontanella1, Paola De Cesaris3, Antonella D’Amore1, Michele Regno1, Donatella Starace1, Fabrizio Padula1, Micol Elena Fiori4, Rita Canipari1, Antonella Stoppacciaro6, Margherita Pesce6, Antonio Filippini1, Antonio Francesco Campese5, Elio Ziparo1,* and Anna Riccioli1,*

1Department of Anatomy, Histology, Forensic Medicine and Orthopaedics, Section of Histology and Medical Embryology, Sapienza University, Rome, Italy

2Department of Experimental Medicine, Sapienza University, Rome, Italy

3Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy

4Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy

5Department of Molecular Medicine, Sapienza University, Rome, Italy

6Division of Pathology, Sant'Andrea University Hospital, Rome, Italy

*These authors have contributed equally to this work

Correspondence to:

Antonio Francesco Campese, email: antonello.campese@uniroma1.it

Antonio Filippini, email: antonio.filippini@uniroma1.it

Keywords: CD44; invasiveness; alternative splicing; prostate stem cells

Received: April 16, 2018     Accepted: June 22, 2018     Published: July 20, 2018

ABSTRACT

In human prostate cancer (PCa), the neuroendocrine cells, expressing the prostate cancer stem cell (CSC) marker CD44, may be resistant to androgen ablation and promote tumor recurrence. During the study of heterogeneity of the highly aggressive neuroendocrine PCa cell lines PC3 and DU-145, we isolated and expanded in vitro a minor subpopulation of very small cells lacking CD44 (CD44neg). Unexpectedly, these sorted CD44neg cells rapidly and spontaneously converted to a stable CD44high phenotype specifically expressing the CD44v8-10 isoform which the sorted CD44high subpopulation failed to express. Surprisingly and potentially interesting, in these cells expression of CD44v8-10 was found to be induced in stem cell medium. CD44 variant isoforms are known to be more expressed in CSC and metastatic cells than CD44 standard isoform. In agreement, functional analysis of the two sorted and cultured subpopulations has shown that the CD44v8-10pos PC3 cells, resulting from the conversion of the CD44neg subpopulation, were more invasive in vitro and had a higher clonogenic potential than the sorted CD44high cells, in that they produced mainly holoclones, known to be enriched in stem-like cells. Of interest, the CD44v8-10 is more expressed in human PCa biopsies than in normal gland. The discovery of CD44v8-10pos cells with stem-like and invasive features, derived from a minoritarian CD44neg cell population in PCa, alerts on the high plasticity of stem-like markers and urges for prudency on the approaches to targeting the putative CSC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25773